The FDA has granted Mesoblast’s stem cell therapy, Ryoncil (remestemcel-L), seven years of orphan drug exclusivity for the ...

Bayer’s Jivi is a factor VIII replacement therapy that has been engineered with a compound that allows for less frequent dosing. It is now indicated for patients 7 years of age and older.

Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System, explains potential ...

Men and people ages 45 and older face additional risk of serious kidney conditions six to 12 months after their viral illness ...

A personalized gene editing therapy was successfully used to treat an infant with CPS1 deficiency, a disease that causes ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Results of a real-world study that included people with hemophilia from 33 countries show that people with hemophilia B, ...

FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Alli Oakes, executive director of research at Trilliant Health, shared that upcoding is a “prime example” of healthcare waste ...

A new law in Iowa, if signed by the governor, will mandate 100% pass-through of rebates, increased financial transparency, ...

New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...